Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-26
1996-12-31
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546243, 546296, 514348, C07D21140, C07D21176, A61K 3144, A61K 31445
Patent
active
055894852
ABSTRACT:
Novel antifungal and antitumor agents having the formula ##STR1## as well as pharmaceutically acceptable salts, esters, amides and pro-drugs thereof, wherein R is selected from the group consisting of ##STR2## Also disclosed are pharmaceutical compositions comprising such compounds, and methods of treatment and processes of manufacture relating thereto.
REFERENCES:
patent: 5002959 (1991-03-01), Konishi et al.
Chemical Abstracts, vol. 81(1) Abstract No. 2395d, Jul. 8, 1974.
Urakawa, et al., Isolation, Structure Determination and Biological Activities of a Novel Antifungal Antibiotic, S-632-C, Closely Related to Glutarimide Antibiotics, Journal of Antibiotics, vol. 46, No. 12, pp. 1827-1833 (Dec. 1993).
Otani, et al., New Glutarimide Antibiotics, S-632-B.sub.a and II. Isolution, Physico-Chemical Properties and Chemical Structure, The Journal of Antibiotics, May, 1989, vol. XLII, No. 5, pp. 654-661.
Otani, et al., New Glutarimide Antibiotics, S-632-B.sub.1 and B.sub.2 I. Taxonomy of Producing Strain, Fermentation and Biological Proprties, The Journal of Antibiotics, May, 1989, vol. XLII, No. 5, pp. 647-653.
Hochlowski Jill E.
Jackson Marianna
Kadam Sunil K.
Karwowski James P.
McAlpine James B.
Abbott Laboratories
Anand Mona
Brainard Thomas D.
Rotman Alan L.
LandOfFree
Dorrigocin antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dorrigocin antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dorrigocin antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142336